TEL AVIV, ISRAEL | Israeli scientists at leading research institutions worldwide are reconnecting with Israelโs domestic scientific and technology ecosystem Tuesday at a global symposium designed to turn cutting-edge academic research into practical solutions.
The Global Israeli Applied Science Symposium 2026, organized by ScienceAbroad, is being held Sept. 8 in Tel Aviv and online, bringing together members of Israelโs scientific diaspora with researchers, entrepreneurs and industry leaders based in the country.
The hybrid gathering is focused on applied science across biotechnology, medicine, chemistry, quantum physics, artificial intelligence and engineering.
ScienceAbroad describes the symposium as a bridge between Israeli researchers abroad and the countryโs research and industry ecosystem, emphasizing interdisciplinary knowledge exchange, international collaboration, and translating scientific discoveries into real-world applications.
The in-person portion will be held at the offices of Israeli law firm Arnon, Tadmor-Levy in Tel Avivโs Azrieli Towers, while scientists and other participants abroad can join via Zoom and Facebook Live.
The symposium runs from 5 p.m. to 8:30 p.m. Israel time, followed by online networking.
Israeli Research From Around The World
The scientific program illustrates the international reach of Israelโs research community.
Among the presenters is Dr. Oren Avram of UCLA, whose work focuses on foundation models for three-dimensional medical imaging and their potential applications in preventive care and clinical trials.
Dr. Alona Shagan Shomron of Germanyโs Max Planck Institute for Intelligent Systems is presenting research on wearable soft robotic devices designed to suppress human tremors.
Dr. Osher Azulay of the University of Michigan is presenting research on fall safety for humanoid robots.
Dr. Tal Gilboa, affiliated with Everest Biolabs and Harvard Universityโs Wyss Institute, is discussing technologies involving extracellular vesicles and their potential use in large-scale translational disease research.
Their participation puts Israeli scientists at major American and European research institutions alongside researchers and entrepreneurs working in Israel.
Israeli-based presentations include work in cancer immunotherapy, genome editing, neuroscience and drug development.
Dr. Diana Gataulin of Virobix and the Weizmann Institute of Science is presenting research on targeted viral RNA delivery for precision cancer immunotherapy.
Dr. Tal Sherman of Israeli agricultural biotechnology company BetterSeeds is discussing how genome editing can reduce allergens in peanuts.
Dr. Ornella Dakwar-Kawar of the Hebrew University of Jerusalem is presenting research examining neural excitation and inhibition in attention deficit hyperactivity disorder and the potential effects of transcranial random noise stimulation.
Dr. Dorit Cohen Carmon of ReSynapse Therapeutics is discussing the development of molecules designed to target multiple receptors for the treatment of post-traumatic stress disorder.
The keynote address is being delivered by Prof. Noam Shomron, a professor at Tel Aviv Universityโs Faculty of Medical and Health Sciences whose research spans genomics, medicine and biotechnology.
Connecting Israelโs Scientific Diaspora
ScienceAbroadโs broader mission is especially important for a country whose scientific talent is distributed among universities, laboratories, and technology companies worldwide.
Israeli researchers regularly pursue postdoctoral positions, faculty appointments and scientific careers at major international institutions. That international presence creates opportunities for collaboration and knowledge exchange, but it also challenges Israel to maintain meaningful connections with scientists building careers abroad.
The symposium is designed to strengthen those connections.
ScienceAbroad says selected presentations feature Israeli postdoctoral researchers and scientists working at leading institutions worldwide, while networking sessions are intended to connect scientists directly with entrepreneurs and industry veterans.
The organization describes the event as a platform for bridging the gap between academic science and industrial application.
That distinction is important.
Scientific discoveries can require years of additional development before they become medicines, medical devices, artificial intelligence systems, engineering products, or commercially viable technologies.
Researchers may have the scientific expertise behind a discovery without access to the business development, financing, regulatory expertise, or industry connections needed to move it beyond the laboratory.
By bringing researchers together with entrepreneurs and industry representatives, the symposium aims to build relationships that can help bridge that divide.
From Scientific Discovery To Practical Impact
The program also reflects the increasing convergence of disciplines within applied science.
Artificial intelligence is becoming deeply integrated into medicine and biomedical research. Robotics increasingly draws upon advances in machine learning, materials science and engineering. Biotechnology combines molecular biology with computational tools, while medical innovation increasingly requires collaboration among researchers, clinicians, engineers and commercial partners.
The Tel Aviv symposium brings these disciplines together in a single program rather than treating them as separate scientific fields.
ScienceAbroad says the objective is to encourage cross-disciplinary idea exchange and create opportunities for international partnerships that can address complex global challenges.
The scientific presentations themselves demonstrate that approach.
The research discussed ranges from AI-assisted medical imaging and precision cancer immunotherapy to humanoid robotics, genome-edited agriculture, neurological treatment, and new approaches to drug development.
A networking session following the scientific presentations is designed to give researchers, entrepreneurs and industry participants an opportunity to establish relationships beyond the formal conference program.
Virtual networking continues online after the in-person scientific sessions conclude.
Israelโs Scientific Network Extends Beyond Its Borders
The symposium comes as Israel continues to build its position in biotechnology, artificial intelligence, medicine, robotics and other research-intensive industries.
Much of that strength originates in Israeli universities and research hospitals, but the countryโs scientific ecosystem extends well beyond Israel itself.
Israeli scientists hold research positions at institutions across North America, Europe, and elsewhere, creating an international network of expertise that can contribute to Israeli science even when researchers remain abroad.
Maintaining those relationships can produce collaborative research, technology transfer, investment connections and commercial partnerships. It can also preserve professional links for scientists who may eventually choose to return to Israel.
ScienceAbroadโs model treats that scientific diaspora not simply as a loss of talent, but as an international resource that can remain connected to Israel.
The Global Israeli Applied Science Symposium aims to turn those connections into tangible collaboration.
For Israel, whose global technology reputation has long depended on its ability to move ideas from laboratories into companies and practical applications, connecting scientists abroad with researchers and entrepreneurs at home offers another way to expand the countryโs innovation ecosystem beyond its geographic borders.
TheJ.ca receives no government money. Independent journalism depends on readers who believe these stories must be told. Consider supporting our efforts.
Stand Proud. Stand Strong. Stand Zionist.
